Quantedge Capital Pte Ltd Sells 47,500 Shares of BlackRock Health Sciences Term Trust $BMEZ

Quantedge Capital Pte Ltd trimmed its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 82.5% in the 2nd quarter, Holdings Channel.com reports. The firm owned 10,054 shares of the company’s stock after selling 47,500 shares during the period. Quantedge Capital Pte Ltd’s holdings in BlackRock Health Sciences Term Trust were worth $143,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of BMEZ. NewEdge Advisors LLC lifted its position in BlackRock Health Sciences Term Trust by 134.3% in the second quarter. NewEdge Advisors LLC now owns 48,300 shares of the company’s stock worth $689,000 after buying an additional 27,686 shares during the last quarter. Rockefeller Capital Management L.P. boosted its position in BlackRock Health Sciences Term Trust by 8.7% in the 2nd quarter. Rockefeller Capital Management L.P. now owns 129,319 shares of the company’s stock valued at $1,844,000 after buying an additional 10,314 shares during the period. Penserra Capital Management LLC grew its stake in BlackRock Health Sciences Term Trust by 3.0% in the second quarter. Penserra Capital Management LLC now owns 1,157,004 shares of the company’s stock worth $16,498,000 after purchasing an additional 34,191 shares in the last quarter. RFG Advisory LLC bought a new stake in shares of BlackRock Health Sciences Term Trust in the second quarter valued at about $858,000. Finally, Apollon Wealth Management LLC purchased a new stake in shares of BlackRock Health Sciences Term Trust in the 2nd quarter worth approximately $341,000.

BlackRock Health Sciences Term Trust Trading Down 1.2%

Shares of NYSE:BMEZ opened at $15.22 on Wednesday. BlackRock Health Sciences Term Trust has a 12-month low of $12.58 and a 12-month high of $16.75. The business’s fifty day simple moving average is $14.99 and its 200-day simple moving average is $14.53.

BlackRock Health Sciences Term Trust Announces Dividend

The company also recently disclosed a monthly dividend, which was paid on Friday, November 28th. Investors of record on Friday, November 14th were paid a dividend of $0.11 per share. This represents a c) annualized dividend and a dividend yield of 8.7%. The ex-dividend date was Friday, November 14th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.